“In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producers of India (OPPI), Indian Pharmaceutical Alliance (IPA), Indian Drug Manufactuers’ Association (IDMA),” said a notice issued by the DoP on the meeting, which be held on November 4.
